P333: Associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics
ECCO '19 Copenhagen
2019
P334: Chromoendoscopy is superior to white light endoscopy for the detection of advanced colonic neoplasia in patients with inflammatory bowel disease
ECCO '19 Copenhagen
2019
P335: Long-term follow-up of switching from original infliximab to infliximab biosimilar: real-world data
ECCO '19 Copenhagen
2019
P336: Behavioural treatment options for psychological comorbidities in patients with inflammatory bowel disease: a systematic literature review
ECCO '19 Copenhagen
2019
P337: Switching from originator infliximab to CT-P13: single-centre experience from the UK
ECCO '19 Copenhagen
2019
P339: Application of Bayesian modelling with infliximab to determine optimal patient-specific regimens
ECCO '19 Copenhagen
2019
P340: Vedolizumab in the treatment of chronic refractory pouchitis: a systematic review
ECCO '19 Copenhagen
2019
P341: Identification and management of psychological distress after stoma surgery: a qualitative study of patients and healthcare professionals
ECCO '19 Copenhagen
2019
P342: A population pharmacokinetic model to support therapeutic drug monitoring during vedolizumab therapy
ECCO '19 Copenhagen
2019
P343: Efficacy of ustekinumab in Crohn’s disease at maintenance Week 56: IM-UNITI study
ECCO '19 Copenhagen
2019
P344: Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study
ECCO '19 Copenhagen
2019
P345: Risk of long-term post-operative recurrence (POR) in Crohn’s disease patients with a first postoperative normal endoscopic assessment under thiopurine prevention
ECCO '19 Copenhagen
2019
P346: Small bowel permeability improves with nutritional therapy in mild-to-moderate active paediatric Crohn’s disease
ECCO '19 Copenhagen
2019
P347: New-onset autoimmune disorders, primarily psoriasis, in anti-TNF biologic exposed paediatric patients: the DEVELOP experience
ECCO '19 Copenhagen
2019
P348: Correlation between Mayo endoscopic score and validated histological score in ulcerative colitis
ECCO '19 Copenhagen
2019
P349: Cyclosporine has no clinically meaningful effect on pharmacokinetics (PK) of BMS-986165, an oral selective tyrosine kinase 2 (TYK2) inhibitor, in healthy subjects
ECCO '19 Copenhagen
2019
P350: Real-world data regarding treatment of ulcerative colitis patients with golimumab in Switzerland
ECCO '19 Copenhagen
2019
P351: MRI outcomes in perianal fistulising Crohn’s disease following anti-TNF-α therapy: a systematic review and meta-analysis
ECCO '19 Copenhagen
2019
P352: TDM of infliximab in IBD-patients: which pharmacokinetic marker to use?
ECCO '19 Copenhagen
2019